… Our knowledge of the mechanisms regulating NLRP3 inflammasome … therapeutic strategies
to treat inflammatory diseases associated with dysregulation of the NLRP3 inflammasome. …

… therapeutic applications targeting the NLRP3 inflammasome to … This review extensively
discusses NLRP3 inflammasome-… the design of therapeutic strategies for NLRP3 inflammasome-…

… therefore blocking NLRP3 inflammasome activation may represent a therapeutic strategy for
… that selectively blocks activation of the NLRP3 inflammasome. In recent years, research on …

… the excitement in the field for NLRP3 as a therapeutic target. As compounds progress, …
strategies have not been published, particularly considering the similar mode of action on NLRP3 …

… blockade to treat NAFLD/NASH, and optimization of the therapeutic strategy for NAFLD
remains a major challenge. Future research directions should focus on agents with good results …

… the effect of the NLRP3 inflammasome on the major cellular … the NLRP3 inflammasome in
DCM and discuss several promising therapeutic strategies targeting the NLRP3 inflammasome …

… There are three approved therapies that target the inflammasome downstream effector IL-1β…
NLRP3 inflammasome activation might represent a better therapeutic strategy to treat NLRP3…

… inflammasome and activation of caspase-1, 5 and has recently emerged as a new therapeutic
strategy … through NLRP3 inflammasome inhibition is hypothesized to be a promising new …

… the NLRP3 inflammasome pathway and alleviate neuroinflammation. Finally, we will summarize
the novel treatment strategies … therapeutic strategies for the treatment of these diseases. …

… NLRP3 inflammasome … NLRP3 inflammasome activation plays a key role in the progression
of MS or EAE. Therefore, targeting the NLRP3 inflammasome might be a therapeutic strategy …